Harmony Biosciences Holdings Inc — Balance Sheet (NASDAQ:HRMY) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 427.07 M433.44 M673.87 M811.45 M999.2 M1.27 B Total liabilities 329.89 M246.94 M271.03 M344.46 M340.05 M401.41 M Total equity 97.18 M186.51 M402.84 M466.99 M659.15 M870.22 M Total liabilities & shareholders' equities 427.07 M433.44 M673.87 M811.45 M999.2 M1.27 B Total debt —————— Net debt ——————

Nachrichten

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

Früherer Generika-Start für Wakix: UBS senkt Kursziel für Harmony Biosciences

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry

Truist bestätigt "Halten"-Rating für Harmony Biosciences mit Kursziel von 25 US-Dollar

Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market